A new treatment for advanced prostate cancer has been approved for use in Scotland, giving medical professionals a new way to tackle the disease.
The Scottish Medicines Consortium (SMC) have sanctioned the use of a novel hormonal therapy by men with metastatic hormone-sensitive prostate cancer.
Joseph Woollcott, policy and health influencing manager at Prostate Cancer UK, welcomed the move. He said: "We are pleased by this decision, which will give men with advanced prostate cancer another life-extending treatment option.